Elevated peri‐transplant distress in caregivers of allogeneic blood or marrow transplant patients
Teresa L. Simoneau(University of Colorado Anschutz Medical Campus), Mark L. Laudenslager(University of Colorado Anschutz Medical Campus), Samuel Philips(University of Colorado Anschutz Medical Campus), Janet Spradley(University of Colorado Denver), Rachel Grzywa‐Cobb(University of Colorado Anschutz Medical Campus), Peter A. McSweeney(Mesoblast (United States)), Kristin Kilbourn(University of Colorado Denver), Susan K. Mikulich‐Gilbertson(University of Colorado Anschutz Medical Campus), Crystal Natvig(University of Colorado Anschutz Medical Campus)
Cited by 80
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
|The Lancet Oncology|2018|2.3k
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k